Cargando…
Benralizumab use in chronic eosinophilic pneumonia with eosinophilic bronchiolitis and chronic airway infection
Chronic eosinophilic pneumonia (CEP) is a rare disorder characterized by marked accumulation of eosinophils in lung tissues and/or bronchoalveolar lavage fluid (BALF). Patients with CEP usually respond well to corticosteroids. However, more than half of these patients relapse while tapering and/or a...
Autores principales: | Takano, Tomotsugu, Inutsuka, Yuh, Nakamura, Satoshi, Ando, Nobuhisa, Komori, Masashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292112/ https://www.ncbi.nlm.nih.gov/pubmed/34306708 http://dx.doi.org/10.1002/rcr2.810 |
Ejemplares similares
-
Eosinophilic bronchiolitis successfully treated with benralizumab
por: Sugino, Keishi, et al.
Publicado: (2021) -
Promising Effects of Benralizumab on Chronic Eosinophilic Pneumonia
por: Isomoto, Kohsuke, et al.
Publicado: (2020) -
Case Report: Eosinophilic Bronchiolitis With Eosinophil ETosis in Mucus Plugs Successfully Treated With Benralizumab
por: Sasaki, Hisashi, et al.
Publicado: (2022) -
Rapid and sustained effects of a single dose of benralizumab on chronic eosinophilic pneumonia
por: Izumo, Takehiro, et al.
Publicado: (2020) -
Successful treatment of acute relapse of chronic eosinophilic pneumonia with benralizumab and without corticosteroids: A case report
por: Izhakian, Shimon, et al.
Publicado: (2022)